From the library

Eighty-six people with migraines practised alternate nostril breathing for three months. Attack frequency fell.

A Cambridge-published 2025 randomised trial put anuloma viloma against a control arm. Three months later, attacks were less frequent and disability scores were lower.

First light along a desert canyon at dawn
First light along a desert canyon at dawn

Migraine sufferers know the cost of a flare in a way no scale really captures. The hours lost. The plans pulled. The slow recovery that costs the next day too. Most of the conversation about prevention lives between medication, sleep, hydration, and avoiding known triggers. A 2025 randomised controlled trial published in Primary Health Care Research and Development by Cambridge University Press adds another option to that conversation. It is one that costs nothing and takes roughly ten minutes.

The trial recruited eighty-six adults with diagnosed migraine attacks and randomised them between a practice arm and a control arm. The intervention was alternate nostril breathing, the structured nasal practice that yoga texts call anuloma viloma. Participants in the practice arm did the technique daily for three months. The control arm received standard care. The investigators measured attack frequency and a disability score that captures how much migraine actually disrupted a person’s daily function.

After three months, the practice arm had significantly fewer migraine attacks per month than the control arm. Their disability scores were also lower. The paper is indexed at PMC11836872 if you want to read the full method.

Why a breathing technique against migraine at all

The mechanism is not magic. There is now a reasonably consistent literature on slow nasal breathing modulating the autonomic nervous system: heart rate variability climbs, sympathetic tone falls, the vagal arm of the parasympathetic system gets more time at the wheel. Migraine is not only an autonomic condition, but autonomic dysregulation is one of the well-documented triggers and amplifiers. A daily practice that nudges the autonomic baseline toward a calmer state, over months, is a plausible way to reduce both attack frequency and intensity. The Cambridge trial does not claim a cure. It claims a measurable reduction in frequency and disability against a control arm over three months. That is exactly what a non-pharmacological adjunct is supposed to do.

A 2026 review just published in Behavioral Sciences through MDPI argues that the limbic system is the place where the effect actually lands. The amygdala and hippocampus get entrained by the slow nasal rhythm. For migraine, where stress reactivity and limbic over-arousal are well-known modulators of attack threshold, that mechanism is a clean fit.

The technique the trial tested

Anuloma viloma is a structured nasal breathing practice that closes one nostril at a time so that air goes in through one side and out through the other. The body alternates which side is open, and the rhythm of breath stays slow and even throughout. It is not a hard practice to learn. The hard part is doing it daily, and that is the part a timer solves.

The trial protocol was ten minutes a day. Most people who get into a routine settle on five to ten minutes once or twice a day. There is no special equipment, no special posture beyond a comfortable upright seat, and no special location. A bedroom chair will do.

Why this trial matters for the larger conversation

For a long time, the public conversation about breathwork has been louder than the evidence base. The last eighteen months have changed that. A Cambridge-published trial on migraine sits alongside a 2025 trial published in Annals of Neuroscience showing that the same technique reduced systolic and diastolic blood pressure in patients already taking medication. It sits alongside trials on anxiety, on heart rate variability after a single session, on resonance frequency breathing in generalised anxiety disorder. The evidence base is now wide enough that practitioners and clinicians can have a real conversation about where structured nasal breathing fits in the standard of care, and the answer is no longer “not yet.”

International Yoga Day arrives this Sunday with the official UN theme of Yoga for Healthy Ageing. The migraine trial fits the theme well. A daily ten-minute practice that reduces attack frequency over three months is exactly the kind of low-cost, low-risk intervention that scales across a long life.

How to start

If you are curious, start with five minutes a day for two weeks before deciding whether you want to continue. The trial used ten minutes. Either is reasonable for a beginner. Pick a time of day you can defend (just after waking and just before sleep are the two anchors most people keep). Find a comfortable seat. Use a timer with a kumbhaka pause built in so you do not have to count.

Anuloma Viloma Timer is free on the App Store. No subscription necessary.

The library